Tooth loss, dementia and neuropathology in the Nun Study

Journal of the American Dental Association

Volumn 138, Issue 10, 2007, Pages 1314-1322

  Stein, Pamela Sparks ^a   Desrosiers, Mark ^b   Donegan, Sara Jean ^c   Yepes, Juan F ^d   Kryscio, Richard J ^d,e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c MARQUETTE UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer disease; Epidemiology; Periodontal disease

Indexed keywords

EID: 35548941094     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0046     Document Type: Article

References (90)

1. Chalmers JM, Carter KD, Spencer AJ. Oral diseases and conditions in community-living older adults with and without dementia. Spec Care Dentist 2003;23(1):7-17.
2. Chalmers JM, Hodge C, Fuss JM, Spencer AJ, Carter KD. The prevalence and experience of oral diseases in Adelaide nursing home residents. Aust Dent J 2002;47(2):123-30.
3. Chapman PJ, Shaw RM. Normative dental treatment needs of Alzheimer patients. Aust Dent J 1991;36(2):141-4.
4. Ghezzi EM, Ship JA. Dementia and oral health. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89(1);2-5.
5. Gordon SR. Survey of dental need among veterans with severe cognitive impairment. Gerodontics 1988;4(4):158-9.
6. Gordon SR, McLain D. Dental needs related to primary cause for institutionalization. Spec Care Dentist 1991;11(2):49-54.
7. Horn VJ, Hodge WC, Treuer JP. Dental condition and weight loss in institutionalized demented patients. Spec Care Dentist 1994;14(3):108-11.
8. Jette AM, Feldman HA, Douglass C. Oral disease and physical disability in community-dwelling older persons. J Am Geriatr Soc 1993;41(10):1102-8.
9. Loesche WJ, Abrams J, Terpenning MS, et al. Dental findings in geriatric populations with diverse medical backgrounds. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80(1):43-54.
10. Nordenram G, Ryd-Kjellen E, Johansson G, Nordstrom G, Winblad B. Alzheimer's disease, oral function and nutritional status. Gerodontology 1996;13(1):9-16.
11. Ship JA. Oral health of patients with Alzheimer's disease. JADA 1992;123(1):53-8.
12. Weyant RJ, Pandav RS, Plowman JL, Ganguli M. Medical and cognitive correlates of denture wearing in older community-dwelling adults. J Am Geriatr Soc 2004;52(4):596-600.
13. Whittle JG, Sarll DW, Grant AA, Worthington HV. The dental health of the elderly mentally ill: a preliminary report. Br Dent J 1987;162(10):381-3.
14. Warren JJ, Chalmers JM, Levy SM, Blanco VL, Ettinger RL. Oral health of persons with and without dementia attending a geriatric clinic. Spec Care Dentist 1997;17(2):47-53.
15. Jones JA, Lavallee N, Alman J, Sinclair C, Garcia RI. Caries incidence in patients with dementia. Gerodontology 1993;10(2):76-82.
16. Ship JA, Puckett SA. Longitudinal study on oral health in subjects with Alzheimer's disease. J Am Geriatr Soc 1994;42(1):57-63.
17. Kondo K, Niino M, Shido K. A case-control study of Alzheimer's disease in Japan: significance of life-styles. Dementia 1994;5(6):314-26.
18. Shimazaki Y, Soh I, Saito T, et al. Influence of dentition status on physical disability, mental impairment, and mortality in institutionalized elderly people. J Dent Res 2001;80(1):340-5.
19. Gatz M, Mortimer JA, Fratiglioni L, et al. Potentially modifiable risk factors for dementia in identical twins. Alzheimer Dement 2006;2:110-17.
20. Stein P, Scheff S, Dawson DR. Alzheimer's disease and periodontal disease: mechanisms underlying a potential bidirectional relationship. Grand Rounds Oral Systemic Med 2006;1:14-24.
21. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontal 2005;76(11 supplement):2106-15.
22. Ebersole JL. Systemic humoral immune responses in periodontal disease. Crit Rev Oral Biol Med 1990;1(4):283-331.
23. Beck JD, Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontal 2002;7(1):79-89.
24. Ebersole JL, Machen RL, Steffen MJ, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997;107(2):347-52.
25. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontal 2000;71(10):1528-34.
26. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontal 2001;72(9):1221-7.
27. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000;79(1):49-57.
28. Bretz WA, Weyant RJ, Corby PM, et al. Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population. J Am Geriatr Soc 2005;53(9):1532-7.
29. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67(10 supplement):1123-37.
30. Elter JR, Offenbacher S, Toole JF, Beck JD. Relationship of periodontal disease and edentulism to stroke/TIA. J Dent Res 2003;82(12):998-1001.
31. Grau AJ, Becher H, Ziegler CM, et al. Periodontal disease as a risk factor for ischemic stroke. Stroke 2004;35(2):496-501.
32. Grau AJ, Buggle F, Ziegler C, et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke 1997;28(9):1724-9.
33. Loesche WJ, Schork A, Terpenning MS, Chen YM, Kerr C, Dominguez BL. The relationship between dental disease and cerebral vascular accident in elderly United States veterans. Ann Periodontol 1998;3(1):161-74.
34. Joshipura KJ, Hung HC, Rimm EB, Willett WC, Ascherio A. Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke 2003;34(1):47-52.
35. Andersen WC, Horton HL. Parietal lobe abscess after routine periodontal recall therapy: report of a case. J Periodontol 1990;61(4):243-7.
36. Andrews M, Farnham S. Brain abscess secondary to dental infection. Gen Dent 1990;38(3):224-5.
37. Brill CB, Pearlstein LS, Kaplan M, Mancall EL. CNS infections caused by Eikenella corrodens. Arch Neurol 1982;39(7):431-2.
38. Emmerson AM, Mills F. Recurrent meningitis and brain abscess caused by Eikenella corrodens. Postgrad Med J 1978;54(631):343-5.
39. Gallagher DM, Erickson K, Hollin SA. Fatal brain abscess following periodontal therapy: a case report. Mt Sinai J Med 1981;48(2):158-60.
40. Goteiner D, Sonis ST, Fasciano R. Cavernous sinus thrombosis and brain abscess initiated and maintained by periodontally involved teeth. J Oral Med 1982;37(3):80-3.
41. Kuijper EJ, Wiggerts HO, Jonker GJ, Schaal KP, de Gans J. Disseminated actinomycosis due to Actinomyces meyeri and Actinobacillus actinomycetemcomitans. Scand J Infect Dis 1992;24(5):667-72.
42. Marks PV, Patel KS, Mee EW. Multiple brain abscesses secondary to dental caries and severe periodontal disease. Br J Oral Maxillofac Surg 1988;26(3):244-7.
43. Martin BF, Derby BM, Budzilovich GN, Ransohoff J. Brain abscess due to Actinobacillus actinomycetemcomitans. Neurology 1967;17(9):833-7.
44. Renton TF, Danks J, Rosenfeld JV. Cerebral abscess complicating dental treatment: case report and review of the literature. Aust Dent J 1996;41(1):12-5.
45. Saal CJ, Mason JC, Cheuk SL, Hill MK. Brain abscess from chronic odontogenic cause: report of case. JADA 1988;117(3):453-5.
46. Zijlstra EE, Swart GR, Godfroy FJ, Degener JE. Pericarditis, pneumonia and brain abscess due to a combined Actinomyces - Actinobacillus actinomycetemcomitans infection. J Infect 1992;25(1):83-7.
47. Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol 2002;17(2):113-8.
48. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261(5123):921-3.
49. Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Nestler EF. The molecular and genetic basis of neurologic and psychiatric disease. 3rd ed. Philadelphia: Butterworth Heinemann; 2003: 337.
50. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 1997;277(10):813-7.
51. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life: findings from the Nun Study. JAMA 1996;275(7):528-32.
52. Riley KP, Snowdon DA, Desrosiers MF, Markesbery WR. Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol Aging 2005;26(3):341-7.
53. Mortimer JA, Gosche KM, Riley KP, Markesbery WR, Snowdon DA. Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study. Neurology 2004;62(3):428-32.
54. Snowdon DA; Nun Study. Healthy aging and dementia: findings from the Nun Study. Ann Intern Med 2003;139(5 pt 2):450-4.
55. Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 2002;51(5):567-77.
56. Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS. Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord 1999;13(4):226-31.
57. Snowdon D, Greiner LH, Riley KP, Markesbery W, Greiner PA, Mortimer JA. Brain infarction and the clinical expression of Alzheimer disease. JAMA 1997;278(2):113.
58. Snowdon DA. Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 1997;37(2):150-6.
59. Jansson H, Lindholm E, Lindh C, Groop L, Bratthall G. Type 2 diabetes and risk for periodontal disease: a role for dental health awareness. J Clin Periodontol 2006;33(6):408-14.
60. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I: clinical and neuropsychological assessment of Alzheimer's disease. Neurol 1989;39(9):1159-65.
61. Potvin AB, Tourtellotte WW, Dailey JS, et al. Simulated activities of daily living examination. Arch Phys Med Rehabil 1972;53(10):476-86.
62. Kruiansky J, Gurland B. The performance test of activities of daily living. Int J Aging Hum Dev 1976;7(4):343-52.
63. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189-98.
64. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease: Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 1998;338(8):506-11.
65. Saunders AM, Hulette O, Welsh-Bohmer KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996;348(9020):90-3.
66. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82(4):239-59.
67. Ohm TG, Muller H, Braak H, Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 1995;64(1):209-17.
68. Allison PD. Survival analysis using the SAS system: A practical guide. Cary, N.C.: SAS Institute; 1995.
69. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21(3):383-421.
70. Amar S, Han X. The impact of periodontal infection on systemic diseases. Med Sci Monit 2003;9(12):RA291-9.
71. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1996;1(1):821-78.
72. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Ann Periodontol 1998;3(1):108-20.
73. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000;157(5):683-94.
74. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 1992;66(2):223-30.
75. Cox G, Gauldie J. Interleukin-6. In: Remick D, Friedland J, eds. Cytokines in health and disease. 2nd ed. New York: Marcel Dekker; 1997: 81-99.
76. Ebersole JL, Cappelli D. Acute-phase reactants in infections and inflammatory diseases. Periodontol 2000 2000;23:19-49.
77. Sheng JG, Ito K, Skinner RD, et al. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 1996;17(5):761-6.
78. Moreira PR, de Sa AR, Xavier GM, et al. A functional interleukin-1 beta gene polymorphism is associated with chronic periodontitis in a sample of Brazilian individuals. J Periodontal Res 2005;40(4):306-11.
79. Cullinan MP, Westerman B, Hamlet SM, et al. A longitudinal study of interleukin-1 gene polymorphisms and periodontal disease in a general adult population. J Clin Periodontol 2001;28(12):1137-44.
80. McDevitt MJ, Wang HY, Knobelman C, et al. Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol 2000;71(2):156-63.
81. Meisel P, Schwahn C, Gesch D, Bernhardt O, John U, Kocher T. Dose-effect relation of smoking and the interleukin-1 gene polymorphism in periodontal disease. J Periodontol 2004;75(2):236-42.
82. Meisel P, Siegemund A, Grimm R, et al. The interleukin-1 polymorphism, smoking, and the risk of periodontal disease in the population-based SHIP study. J Dent Res 2003;82(3):189-93.
83. Parkhill JM, Hennig BJ, Chapple IL, Heasman PA, Taylor JJ. Association of interleukin-1 gene polymorphisms with early-onset periodontitis. J Clin Periodontol 2000;27(9):682-9.
84. Engebretson SP, Lamster IB, Herrera-Abreu M, et al. The influence of interleukin gene polymorphism on expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissue and gingival crevicular fluid. J Periodontol 1999;70(6):567-73.
85. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22(6):396-402.
86. Grimaldi LM, Casadei VM, Ferri C, et al. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 2000;47(3):361-5.
87. Rebeck GW. Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. Neurosci Lett 2000;293(1):75-7.
88. Yucesoy B, Peila R, White LR, et al. Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiol Aging 2006;27(2):211-7.
89. Mrak RE, Griffin WS. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 2001;22(6):903-8.
90. Sanz M, Newman MG, Quiryhem M. Advanced diagnostic techniques. In: Takei H, Newman MG, Klokkevold P, Carranza F, eds. Clinical periodontology. 10th ed. St. Louis: Saunders Elsevier; 2006: 585.